Gilotrif 20 mg/1 (Afatinib TABLET, FILM COATED) 20 mg/1

Gilotrif 20 mg tablets are a prescription medication used to treat certain types of cancer. This film-coated tablet is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc. in the USA.

Strength

20 mg/1

Pack Size

1 BOTTLE in 1 CARTON (0597-0141-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gilotrif 20 mg tablets are typically used in the treatment of non-small cell lung cancer (NSCLC) with specific genetic markers. Afatinib, the active ingredient, is designed to target and inhibit certain proteins that contribute to cancer cell growth. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Side Effects

Common effects of Gilotrif 20 mg tablets may include skin rash, diarrhea, and nausea. Some users might experience appetite loss or fatigue. These effects can vary in intensity and duration among individuals. It is important to monitor any persistent or severe symptoms and discuss them with a healthcare professional.

Precautions & Warnings

Gilotrif 20 mg tablets should be handled with care and stored as directed. This medication is intended for oral use only. Patients should follow their healthcare provider's instructions regarding dosage and administration. It is crucial to inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

Gilotrif 20 mg tablets may interact with certain medications, including those that affect liver enzymes. Alcohol consumption should be avoided while taking this medication. Patients should also be cautious with other medications that may cause similar side effects, such as gastrointestinal issues or skin reactions.

Frequently Asked Questions

Gilotrif 20 mg tablets are used to treat non-small cell lung cancer (NSCLC) with specific genetic markers.

Gilotrif 20 mg tablets are taken orally, typically once daily. Follow your healthcare provider's instructions for proper administration.

Common side effects may include skin rash, diarrhea, nausea, appetite loss, and fatigue.

It is generally advised to avoid alcohol while taking Gilotrif 20 mg tablets to prevent potential interactions.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.